| 标题 |
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Nature Cancer 作者:Peter Schmid; Seock-Ah Im; Zbigniew Nowecki; Piotr J. Wysocki; Jacek Jassem; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)